There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments?
This article by Jason Najum was originally published on Microdose Psychedelic Insights and appears here with permission.
The psychedelic medicine industry continues to get attention and gain credibility in the investment world.
Bright Minds’ Second-Gen Psychedelic Drugs Ready to Be Embraced by Investors, Big Pharma
Bright Minds Biosciences (OTC: BMBIF), a Canadian-based biotechnology company, is developing the next-generation serotonergic drugs to treat various central nervous system (CNS) disorders.
Benzinga Cannabis Capital Conference – June 4 Agenda
The premier gathering of cannabis entrepreneurs and investors in North America returns for an all-day virtual event on June 3-4.